{"id":"https://openalex.org/W3018867154","doi":"https://doi.org/10.1093/rheumatology/keaa111.209","title":"P214 Preliminary results: driving improvements in disease outcomes for rheumatoid arthritis patients using remote disease activity monitoring via smartphone app","display_name":"P214 Preliminary results: driving improvements in disease outcomes for rheumatoid arthritis patients using remote disease activity monitoring via smartphone app","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3018867154","doi":"https://doi.org/10.1093/rheumatology/keaa111.209","mag":"3018867154"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/keaa111.209","doi":"https://doi.org/10.1093/rheumatology/keaa111.209","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaa111.209","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016112186","display_name":"Amy MacBrayne","orcid":"https://orcid.org/0000-0001-9745-3089","observed_orcids":["https://orcid.org/0000-0001-9745-3089"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amy C. B MacBrayne","raw_affiliation_strings":["Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021185078","display_name":"Jason Pott","orcid":"https://orcid.org/0000-0003-2068-0560","observed_orcids":["https://orcid.org/0000-0003-2068-0560"]},"institutions":[{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jason Pott","raw_affiliation_strings":["Emergency Medicine, Royal London Hosptial, Barts Health NHS Trust, LONDON, UNITED KINGDOM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergency Medicine, Royal London Hosptial, Barts Health NHS Trust, LONDON, UNITED KINGDOM","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035885005","display_name":"Vladan Petrovi\u0107","orcid":"https://orcid.org/0000-0002-4858-1161","observed_orcids":["https://orcid.org/0000-0002-4858-1161"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vladan Petrovic","raw_affiliation_strings":["Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057803401","display_name":"Costantino Pitzalis","orcid":"https://orcid.org/0000-0003-1326-5051","observed_orcids":["https://orcid.org/0000-0003-1326-5051"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Costantino Pitzalis","raw_affiliation_strings":["Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000934212","display_name":"Frances Humby","orcid":"https://orcid.org/0000-0003-1280-9133","observed_orcids":["https://orcid.org/0000-0003-1280-9133"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frances Humby","raw_affiliation_strings":["Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary, University of London, Experimental Medicine & Rheumatology, LONDON, UNITED KINGDOM","institution_ids":["https://openalex.org/I166337079"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3486,"currency":"GBP","value_usd":4597},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"59","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.5713000297546387,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.5713000297546387,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11446","display_name":"Mobile Health and mHealth Applications","score":0.42160001397132874,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":1.0},{"id":"https://openalex.org/keywords/disease-activity-monitoring","display_name":"disease activity monitoring","score":0.7070000171661377},{"id":"https://openalex.org/keywords/mobile-application","display_name":"mobile application","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.7960000038146973},{"id":"https://openalex.org/keywords/das28","display_name":"DAS28","score":0.7229999899864197},{"id":"https://openalex.org/keywords/medication-tracking","display_name":"medication tracking","score":0.3930000066757202},{"id":"https://openalex.org/keywords/co-design","display_name":"co-design","score":0.5509999990463257},{"id":"https://openalex.org/keywords/feasibility-and-acceptability","display_name":"feasibility and acceptability","score":0.6389999985694885},{"id":"https://openalex.org/keywords/remote-monitoring","display_name":"remote monitoring","score":0.3630000054836273},{"id":"https://openalex.org/keywords/tender-and-swollen-joint-count","display_name":"swollen and tender joint count","score":0.6629999876022339},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.7139999866485596},{"id":"https://openalex.org/keywords/abatacept","display_name":"abatacept","score":0.9750000238418579},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.7039999961853027},{"id":"https://openalex.org/keywords/certolizumab","display_name":"certolizumab","score":0.9760000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9606665372848511},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6566453576087952},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5966993570327759},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.49825453758239746},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4898678958415985},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.451425701379776},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4166174530982971}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/rheumatology/keaa111.209","doi":"https://doi.org/10.1093/rheumatology/keaa111.209","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaa111.209","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7159986045","https://openalex.org/W2553207709","https://openalex.org/W2800326521","https://openalex.org/W2937510632","https://openalex.org/W4366831721","https://openalex.org/W4238486487","https://openalex.org/W3020288270","https://openalex.org/W7141011826","https://openalex.org/W4283011357","https://openalex.org/W2556638574"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Biologic":[2],"dose":[3,106,446],"tapering":[4,107,390],"in":[5,132,163,183,201,434],"RA":[6,109,113],"is":[7,20,418],"attractive":[8],"due":[9,233],"to":[10,52,77,90,103,120,148,181,195,217,234,236,381,397,432],"the":[11,92,133,193,211,227],"reduced":[12,16],"costs,":[13],"and":[14,55,62,76,95,125,159,214,286,379,421,429],"potentially":[15],"risks,":[17],"although":[18],"there":[19],"a":[21,73,100,121,141,291,303,389,402,419],"significant":[22],"risk":[23],"of":[24,86,97,176,299,340,360,401],"disease":[25,41,186,435],"flare.":[26],"Capturing":[27],"flares":[28,200],"can":[29],"be":[30,53,182],"challenging":[31],"within":[32,376],"current":[33],"NHS":[34],"clinic":[35],"frameworks":[36],"with":[37,140,165],"limited":[38],"capacity.":[39],"Remote":[40],"monitoring":[42,101,428],"through":[43],"patient":[44,80,150,230,323,329,393],"collected":[45],"joint":[46,82,137,157,407],"counts":[47],"has":[48],"previously":[49],"been":[50],"demonstrated":[51],"feasible":[54],"reliable.":[56],"BioT-app":[57,98],"was":[58,89,231,246,261,319,326,394],"co-designed":[59],"by":[60,210,372,405],"clinicians":[61],"patients":[63,114,223,273,300,341,354,369,386,439],"using":[64],"an":[65],"iterative":[66],"collaborative":[67],"design":[68],"process.":[69],"It":[70],"functions":[71],"as":[72,99],"medication":[74],"tracker":[75],"remotely":[78],"collect":[79],"recorded":[81],"counts.":[83],"The":[84,243],"aim":[85],"this":[87],"study":[88,124],"establish":[91],"validity,":[93],"acceptability,":[94],"feasibility":[96],"tool":[102,423],"support":[104],"biologic":[105,167,293,441],"for":[108,127,136,189,438],"patients.":[110],"Methods":[111],"30":[112],"on":[115,276,290,302,333,388,440],"injectable":[116],"biologics":[117,365],"were":[118,172,191,224,252,255,275,289,301,366],"recruited":[119],"prospective,":[122],"observational":[123],"followed":[126],"6":[128,280],"months.":[129],"Those":[130],"enrolled":[131,225],"app":[134],"attended":[135],"count":[138,408],"training,":[139],"second":[142],"remote":[143,427],"assessment":[144],"1":[145],"week":[146],"later":[147],"confirm":[149],"reproducibility.":[151],"Patients":[152,179],"submitted":[153,307,324],"tender":[154],"&":[155,268],"swollen":[156],"counts,":[158],"global":[160],"VAS":[161],"scores":[162,171,309,437],"line":[164],"their":[166,197,238,334,361,382],"dosing":[168],"schedule.":[169],"DAS28":[170,202],"completed":[173,342,348],"following":[174,399],"entry":[175],"ESR/CRP":[177],"levels.":[178],"observed":[180],"persistent":[184],"low":[185],"activity":[187,436],"(DAS<3.3":[188],">6/12)":[190],"offered":[192],"opportunity":[194],"taper":[196],"biologic.":[198],"Significant":[199],"(>1.2":[203],"or":[204],"any":[205],"score":[206,318],">5.1)":[207],"triggered":[208],"contact":[209],"clinical":[212],"team":[213],"early":[215],"face":[216,218],"review":[219],"offered.":[220],"Results":[221],"Thirty":[222],"into":[226],"study.":[228],"One":[229,328,392],"withdrawn":[232],"inability":[235],"submit":[237],"initial":[239,322,335],"test-tracking":[240],"DAS":[241,308,317,325,344],"score.":[242],"mean":[244,321],"age":[245],"56.7":[247],"years":[248],"(range":[249],"28-81),":[250],"56.7%":[251],"female;":[253],"86.7%":[254],"sero-positive":[256],"(ACPA":[257],"and/or":[258],"RF).":[259],"Ethnicity":[260],"60%":[262],"White":[263,270],"British:":[264],"27%":[265],"South":[266],"Asian":[267],"13%":[269],"Other.":[271],"Twenty":[272],"(69%)":[274],"TNFi":[277],"(8":[278],"etanercept;":[279],"certolizumab;":[281],"3":[282,284,296,377],"adalimumab;":[283],"golimumab),":[285],"nine":[287],"(31%)":[288],"non-TNFi":[292],"(6":[294],"tocilizumab;":[295],"abatacept).":[297],"48%":[298],"weekly":[304],"schedule,":[305],"so":[306],"weekly;":[310],"35%":[311],"fortnightly;":[312],"17%":[313],"monthly.":[314],"Mean":[315],"baseline":[316,383],"2.43,":[320],"3.09.":[327],"underwent":[330],"re-training":[331],"based":[332],"self-submitted":[336],"DAS.":[337],"12/31":[338],"(41%)":[339],"every":[343],"score;":[345],"8/31":[346],"(28%)":[347],">80%":[349],"scores;":[350],"5/31":[351],">60%.":[352],"Four":[353,363],"(13.8%)":[355],"input":[356],"less":[357],"than":[358],"50%":[359],"scores.":[362],"patients\u2019":[364],"tapered.":[367],"Two":[368,385],"flared,":[370],"defined":[371],"DAS-28":[373],"increase":[374],">0.6":[375],"weeks,":[378],"returned":[380],"regimen.":[384,391],"remained":[387],"switched":[395],"back":[396],"bio-originator":[398],"submission":[400],"DAS>5.1,":[403],"confirmed":[404],"physician":[406],"during":[409],"face-to-face":[410],"consultation.":[411],"Conclusion":[412],"Preliminary":[413],"results":[414],"suggest":[415],"that":[416],"BioT-App":[417],"reliable":[420],"acceptable":[422],"which":[424],"facilitates":[425],"enhanced":[426],"rapid":[430],"response":[431],"changes":[433],"therapy,":[442],"including":[443],"those":[444],"undergoing":[445],"tapering.":[447],"Disclosures":[448],"A.C.B.":[449],"MacBrayne":[450],"None.":[451,454,457,460,463],"J.":[452],"Pott":[453],"V.":[455],"Petrovic":[456],"C.":[458],"Pitzalis":[459],"F.":[461],"Humby":[462]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-05-01T00:00:00"}